World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
82
Citations
25841
World Ranking
1504
National Ranking
47

Overview

Ben Schmand is a researcher affiliated with the University of Amsterdam in the Netherlands, specializing in medicine and neuroscience. Their research covers a range of subfields including psychiatry and mental health, cognitive neuroscience, neurology, experimental and cognitive psychology, and health. The scientist has contributed notably to topics such as dementia and cognitive impairment research, Parkinson's disease mechanisms and treatments, functional brain connectivity studies, cognitive functions and memory, health disparities and outcomes, frailty in older adults, and neural and behavioral psychology studies.

Among recent publications, Ben Schmand has authored significant papers including:

  • Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines (2020, UNC Libraries)
  • The Factor Structure of Cognitive Functioning in Cognitively Healthy Participants: a Meta-Analysis and Meta-Analysis of Individual Participant Data (2020, Neuropsychology Review)
  • Mapping the multicausality of Alzheimer's disease through group model building (2020, GeroScience)
  • Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline (2021, JAMA Network Open)
  • Migration and dementia: a meta-analysis of epidemiological studies in Europe (2020, Psychological Medicine)

Ben Schmand has published several works in frequent academic venues, with notable contributions in The Clinical Neuropsychologist, Neurology, Frontiers in Psychology, UNC Libraries, and Neuropsychology Review. The distribution of publications reflects interdisciplinary engagement across clinical neuropsychology and neurology primarily.

In collaboration, Ben Schmand has worked extensively with co-authors including Gijs van Elswijk, Mandy Spaltman, Stefan Vermeent, Edward H.F. de Haan, and Selma Lugtmeijer, indicating a professional network with repeated scientific partnerships.

The main fields of study emphasize medicine and neuroscience with a strong emphasis on mental health and cognitive sciences. Subfields show a broad spectrum from psychiatry and mental health to experimental psychology, illustrating a holistic approach to understanding cognitive and neurological conditions.

Research themes frequently addressed involve:

  • Dementia and Cognitive Impairment Research
  • Parkinson's Disease Mechanisms and Treatments
  • Functional Brain Connectivity Studies
  • Cognitive Functions and Memory
  • Health disparities and outcomes
  • Frailty in Older Adults
  • Neural and Behavioral Psychology Studies

Best Publications

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • Cognitive profile of patients with newly diagnosed Parkinson disease

    Dino Muslimović;Bart Post;Johannes D. Speelman;Ben Schmand

  • Are memory complaints predictive for dementia? A review of clinical and population-based studies

    Cees Jonker;Mirjam I Geerlings;Ben Schmand

  • Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial

    Vincent J J Odekerken;Teus van Laar;Michiel J Staal;Arne Mosch

  • Association Between Memory Complaints and Incident Alzheimer’s Disease in Elderly People With Normal Baseline Cognition

    Mirjam I. Geerlings;Cees Jonker;Lex M. Bouter;Herman J. Adèr

  • Visual association test to detect early dementia of the Alzheimer type

    J Lindeboom;B Schmand;L Tulner;G Walstra

  • Subjective memory complaints may announce dementia.

    Ben Schmand;Cees Jonker;Chris Hooijer;Jaap Lindeboom

  • Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.

    M.I. Geerlings;R.A. Schoevers;A. Beekman;C. Jonker

  • De Nederlandse Leestest voor Volwassenen: een maat voor het premorbide intelligentieniveau

    Ben A. Schmand;Dik Bakker;Rolf J. Saan;Jorinde Louman

  • Determinants of disability and quality of life in mild to moderate Parkinson disease

    D. Muslimovic;B. Post;J.D. Speelman;B. Schmand

  • Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

    Pieter Jelle Visser;Philip Scheltens;Frans R.J. Verhey;Ben Schmand

  • Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

    Olivia Skrobot;Sandra Black;Christopher Chen;Charles Decarli

  • The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis.

    B.A. Schmand;J.H. Smit;M.I. Geerlings;J. Lindeboom

  • The cognitive profile of ALS: a systematic review and meta-analysis update

    Emma Beeldman;Joost Raaphorst;Joost Raaphorst;Michelle Klein Twennaar;Marianne de Visser

  • Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study

    H.M.M. Smeding;J.D. Speelman;M. Koning-Haanstra;P.R. Schuurman

  • Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease

    H M M Smeding;A E Goudriaan;E M J Foncke;P R Schuurman

  • GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up

    Vincent J J Odekerken;Judith A Boel;Ben A Schmand;Rob J de Haan

  • Subjective memory complaints in the elderly: depressive symptoms and future dementia.

    B.A. Schmand;C. Jonker;M.I. Geerlings;J. Lindeboom

  • Memory disturbances in Ecstasy users are correlated with an altered brain serotonin neurotransmission

    L. Reneman;J. Booij;B. Schmand;W. van den Brink

  • Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.

    L Reneman;J Lavalaye;B Schmand;F A de Wolff

  • Cognitive complaints in patients after whiplash injury: the impact of malingering

    B.A. Schmand;J. Lindeboom;S. Schagen;R. Heijt

Frequent Co-Authors

Hilde M. Huizenga
Hilde M. Huizenga University of Amsterdam
Peter Reiss
Peter Reiss University of Amsterdam
Jennifer G. Goldman
Jennifer G. Goldman Shirley Ryan AbilityLab
Dick J. Veltman
Dick J. Veltman Amsterdam UMC
James H. Cole
James H. Cole University College London
Irene Litvan
Irene Litvan University of California, San Diego
João Maroco
João Maroco ISPA - University Institute of Psychological, Social and Life Sciences
Danielle C. Cath
Danielle C. Cath Utrecht University
Caroline Sabin
Caroline Sabin University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ben Schmand

Trending Scientists

Recently Published Articles